“…Unfortunately, even though Latin America comprises 20 countries and more than 600 million people, very few longitudinal FE studies have been conducted and only a handful of specialized FE teams have been established, mostly in Brazil, Chile and Mexico (Aceituno et al, 2020). Based on our literature review, we just found three clinical trials (Apiquian et al, 2003;Valencia et al, 2012;Valencia et al, 2017), few reports describing a naturalistic follow-up of clinical samples (Attux et al, 2007;Trzesniak et al, 2012;Gonzalez-Valderrama., 2017;Cano et al, 2021), a number of short, acute treatment studies used to examine neuroimaging or genetic markers (De La Fuente-Sandoval et al, 2013;Santoro et al, 2018) or chart reviews with a longitudinal component (Gomez-de-Regil et al, 2010;Markkula et al, 2011;Mena et al, 2018).…”